$NVAX
Novavax Inc
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$9.50
▲+2.15%+$0.200
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateNovavax Inc
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is NVAX up today? It is at $9.50 (+2.15%), and our scanner flagged it 222 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment NVAX spikes, and full due diligence on NVAX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $NVAX 222 times in the last 30 days. Create a free account to track $NVAX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on NVAX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for NVAX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystResults of OperationsReported 10 Adjustments: R&D Reimbursement 22.6 6.5 50.3 17.7 Non-GAAP Combined R&D and SG&A Expenses $74.8 $116.4 $171.3 $242.1 Contacts: Investors Naina Zaman 240-410-5353 ir@novavax.com Media Yvonne Sprow 844-264-8571 media@novavax.com, from an SEC filing. Read it →Latest filingSC 13GPassive 5%+ stake disclosedAug 7, 2026 · 36 days agoSources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Alton Gregg H Director | Other | 19K 0.01% of company | added 66% | 48K | n/a | Jun 20, 26 |
Mott David M Director | Other | 19K 0.01% of company | added 31% | 80K | n/a | Jun 20, 26 |
Mcglynn Margaret G Director | Other | 19K 0.01% of company | added 74% | 44K | n/a | Jun 20, 26 |
Douglas Richard Director | Other | 19K 0.01% of company | added 35% | 73K | n/a | Jun 20, 26 |
King Rachel K. Director | Other | 19K 0.01% of company | added 75% | 44K | n/a | Jun 20, 26 |
Rodgers Richard J Director | Other | 19K 0.01% of company | added 66% | 47K | n/a | Jun 20, 26 |
Newton Charles W. Director | Other | 10K | n/a | 10K | n/a | Apr 25, 26 |
Shiver John W. Director | Other | 8K | n/a | 8K | n/a | Mar 10, 26 |
Kelly James Patrick Officer | Sold (automatic/other) | -6K | sold 4.3% | 131K | $59K at $9.98 | Mar 7, 26 |
Kelly James Patrick Officer | Other | 12K | added 9.8% | 137K | n/a | Mar 7, 26 |
Draghia-Akli Ruxandra Officer | Sold (automatic/other) | -11K | sold 32% | 24K | $107K at $9.49 | Mar 3, 26 |
Draghia-Akli Ruxandra Officer | Other | 27K 0.02% of company | added 100% | 35K | n/a | Mar 3, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on NVAX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for NVAX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
NVAX last traded at $9.50, up 2.15% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Novavax Inc (NVAX) is next expected to report earnings on Thursday, November 5, 2026, about 53 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
Yes. NVAX currently has a dividend yield of about 13.54% ($1.27 per share per year). Dividend figures can change; this is not investment advice.
The NVAX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged NVAX 222 times in the last 30 days.
NVAX (Novavax Inc) trades on XNAS, with a market cap of about $1.55B in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge NVAX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$NVAX discussion
Sign in to ask a question or join the discussion.